Prime Medicine

Prime Medicine: Series B Funding Round

Prime Medicine has successfully raised $315M in Series B funding, reaching a valuation of $1.85B.

Company Overview

Prime editing gene therapy

Funding Details

The Series B round was led by GV, with participation from F-Prime Capital, Westlake Village BioPartners, ARCH Venture Partners, Deerfield Management.

Company Information

• Headquarters: 800 Boylston Street, Boston, MA 02199
• Founded: 2019
• Employees: 250+
• Category: Biotech

Investment

Prime Medicine plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

• GV: Verified investor in Series B
• F-Prime Capital: Verified investor in Series B
• Westlake Village BioPartners: Verified investor in Series B
• ARCH Venture Partners: Verified investor in Series B
• Deerfield Management: Verified investor in Series B